MedPath

Studying the effects of dexamethasone in the prevention of nausea and vomiting and postoperative pain in patients undergoing abdominal hysterectomy

Phase 2
Recruiting
Conditions
Hysterectomy.
Acquired absence of genital organ(s)
Registration Number
IRCT20161220031487N8
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
102
Inclusion Criteria

Age over 30 years
Candidate for abdominal hysterectomy
Body mass index (BMI) from 20-35

Exclusion Criteria

Systemic disease such as diabetes, asthma or cancer
History of allergy to dexamethasone
Nausea and vomiting in 24 hours prior to operation
Receiving anti-emetics 48 hours before operation
Digestive system anomalies such as gastritis and esophagitis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath